BackgroundVascular access is a rate‐limiting step for peripheral blood stem cell collection. In the absence of readily accessible superficial veins, placement of tunnelled or non‐tunnelled central venous catheters (CVCs) is common. These invasive access routes create medical risks for patients and are associated with logistical challenges, thus prompting a search for alternatives. One such option is the off‐label use of midline catheters.Study design and methodsWe carried out a literature search for published experience with the use of midline catheters for peripheral blood stem cell collection. Data extracted included whether collections were allogeneic or autologous, donor sex, age and weight, inlet flow rate, total blood volumes (TBV) processed, collection duration, number of collections per donor, and achievement of collection targets.ResultsThe search produced three reports (one in abstract form) comprising 19 patients and 26 collection events. Donor sex and status were provided for 18 patients; 10 were female, 8 were male, 12 were allogeneic, and 6 autologous. Median (range) for: donor age was 28 (12–59); donor body weight (kg) was 77.5 (45.4–113.4); inlet flow rate (in mL/min) was 66 (28–80); TBV processed (in mL) was 15,880 (6178–21,871); collection duration (in hours) was 5.0 (3.2–7.0); and CD34 × 106/kg collection yield was 5.9 (3.6–23.0). Target CD34 yields were achieved in 14/19 (74%) of donors with 7/19 (37%) requiring two collections days.DiscussionPeripheral blood stem cell collection does appear to be viable via midline‐based catheter access, particularly for allogeneic donors and shorter collection courses. Development of institution‐specific guidelines and care pathways are recommended.